Dermagnostix GmbH

Dermagnostix, a spin-off company, emerged from the collaborative efforts of the Hahn-Schickard Institut, the Helmholtz Zentrum München, and TU Munich, leveraging decades of sophisticated research in dermatology, immunology, bioinformatics, and microfluidics. The company focuses on advancing diagnostics in dermatology by providing innovative molecular diagnostic solutions tailored for diagnostic laboratories, dermatologists, and research organizations in academia and pharmaceuticals. Dermagnostix`s products are designed for automation and precision in diagnosis, allowing skin experts to make informed treatment decisions. The company`s strategic acquisition of the DiskReader business and fluorescence detector technology in July 2025 marked a pivotal expansion, enhancing in-house production capabilities and endorsing technological autonomy.